Lataa...
Antithrombin in sepsis revisited
As the pivotal phase III randomized controlled clinical trial on antithrombin concentrate in patients with severe sepsis did not show a beneficial effect of antithrombin treatment on 28-day mortality, the interest in the potential use of this treatment modality in sepsis has diminished. However, rec...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2005
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1414019/ https://ncbi.nlm.nih.gov/pubmed/16356248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3819 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|